SCHEMBL3485367

SCHEMBL3485367

CCCOc1ccccc1/C=C/C(CCc1ccc(C(=O)O)cc1)Cc1ccc(C(=O)O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.43
KDM4E B2RXH2 3/20 0.43
MAPT P10636 3/20 0.43
ALDH1A1 P00352 3/20 0.43
PPARG P37231 3/20 0.43
CRHBP P24387 2/20 0.43
CRHR2 Q13324 2/20 0.43
PSMD14 O00487 1/20 0.43
HPGD P15428 1/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
MEN1 O00255 3/20 0.41
PTGER1 P34995 1/20 0.41
PTGER4 P35408 1/20 0.41
PTGER3 P43115 1/20 0.41
PTGER2 P43116 1/20 0.41
PTGES O14684 2/20 0.39
ALOX5 P09917 2/20 0.39
GAA P10253 1/20 0.39
RXRA P19793 2/20 0.39
RXRB P28702 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3485369 1.00 KMT2A (0.43) KMT2AKDM4EMAPTALDH1A1PPARG
SCHEMBL8242476 0.96 PPARG (0.40) KMT2AKDM4EMAPTALDH1A1PPARG
SCHEMBL3484551 0.95 PPARG (0.43) KMT2AKDM4EMAPTALDH1A1PPARG
SCHEMBL3484545 0.95 PPARG (0.43) KMT2AKDM4EMAPTALDH1A1PPARG
SCHEMBL3484556 0.94 RARB (0.43) KMT2AKDM4EMAPTALDH1A1PPARG
SCHEMBL3484553 0.94 RARB (0.43) KMT2AKDM4EMAPTALDH1A1PPARG
SCHEMBL3484753 0.93 TP53 (0.44) KMT2AMAPTALDH1A1MEN1
SCHEMBL3484751 0.93 TP53 (0.44) KMT2AMAPTALDH1A1MEN1
SCHEMBL3484798 0.93 TP53 (0.44) KMT2AMAPTALDH1A1MEN1
SCHEMBL3484802 0.93 TP53 (0.44) KMT2AMAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940769-B1 DICARBOXYLIC ACID DERIVATIVES AND THEIR USE BAYER IP GMBH (DE) 2016-08-10 EP disclosed
EP-1940769-B1 DICARBOXYLIC ACID DERIVATIVES AND THEIR USE BAYER IP GMBH (DE) 2016-08-10 EP disclosed
US-20100029772-A1 Dicarboxylic Acid Derivatives and their Use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-04 US disclosed
US-20100029772-A1 Dicarboxylic Acid Derivatives and their Use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-04 US disclosed
US-20100029772-A1 Dicarboxylic Acid Derivatives and their Use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029772-A1 Dicarboxylic Acid Derivatives and their Use PC, SLC25A1, GOT2 KMT2A 2396/4885KDM4E 2369/4885MAPT 2840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.